Skip to main content
Aprogen, Inc logo

Aprogen, Inc — Investor Relations & Filings

Ticker · 007460 ISIN · KR7007460009 KO Manufacturing
Open in API
Filings indexed 735 across all filing types
Latest filing 2024-04-12 Major Shareholding Noti…
Country KR South Korea
Listing KO 007460

About Aprogen, Inc

https://www.aprogen.com/en/v.do?a=Main

Aprogen, Inc. is a biopharmaceutical company focused on the research, development, and manufacturing of biologic medicines. The company's core activities are centered on developing both biosimilars and novel drugs, including new protein therapeutics and bispecific antibodies. Its product development is based on proprietary technologies in antibody engineering and recombinant protein engineering.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a mandatory regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, including special relationships and collateral agreements. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2024-04-12 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting, including financial statement approval, dividend status, director/auditor appointments, and other agenda items. This fits the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA), as it reports the official outcomes of shareholder votes at an AGM.
2024-04-05 Korean
주요사항보고서(자기전환사채매도결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) filed with the Financial Services Commission in South Korea. It specifically details the company's decision to sell its own convertible bonds (자기전환사채매도결정). This type of transaction relates to the company's capital structure and financing activities. Since it involves the sale of financial instruments (convertible bonds) rather than a share buyback or issuance, it falls under the 'Capital/Financing Update' category.
2024-04-05 Korean
주권관련사채권의처분결정(종속회사의주요경영사항)
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from a Korean company (Aprogen) regarding the disposal of convertible bonds held by its subsidiary (AP Healthcare). It details the transaction, the purpose (liquidity), and financial impact, which is a standard corporate disclosure of a material event. Since it involves the disposal of financial assets (bonds) and does not fit into specific categories like M&A, share issuance, or director dealings, it falls under the general regulatory filing category.
2024-04-05 Korean
주식등의대량보유상황보고서(일반)
Regulatory Filings Classification · 100% confidence The document is a 'Report on Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details the shareholding status, changes in ownership, and collateral agreements of major shareholders of the company 'Aprogen'. This type of filing is a mandatory regulatory disclosure regarding significant ownership thresholds and does not fit into specific categories like earnings releases or annual reports, making 'RNS' (Regulatory Filings) the most appropriate classification.
2024-03-29 Korean
사업보고서 (2023.12)
Audit Report / Information Classification · 100% confidence The document is a comprehensive financial report titled '재무제표에 대한 감사보고서' (Audit Report on Financial Statements) for the company '주식회사 에이프로젠'. It includes the independent auditor's report, financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes. This is a formal audit report covering the fiscal year 2023, which falls under the 'Audit Report / Information' category. FY 2023
2024-03-28 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.